This recertification of Company's OECD GLP is testimony to company's unwavering commitment to maintain international quality standards at the facility
The FDA issued Form 483 with one observation related to building and facility management
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
30th Lab in Thyrocare’s expanding network to bring advanced, affordable diagnostics in Bihar and beyond
This significant milestone enhances our global regulatory standing
These observations are procedural in nature and none of them are related to data integrity
The Q1 2025 also witnessed a successful launch of Allegra D
Niacin is indicated to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides (TG)
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
Subscribe To Our Newsletter & Stay Updated
